Medifast (MED) risk factors, FY2024 10-K

Medifast's FY2024 10-K, filed Feb 18, 2025, lists 29 risk factors in 3 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
293 groups
Section length
8k wordsItem 1A

Medifast's biggest risks in the FY2024 10-K

  • Medifast faces intense competition from weight-loss medicines and shifting consumer preference toward integrated lifestyle approaches.

The risks most specific to Medifast

  • Risks Related to Our Business

    The weight management industry is highly competitive and the development and acceptance of weight-loss medicines and other products could result in decreased demand for our services and products

    The weight management industry is highly competitive, and the growth of weight-loss medicines and other products could decrease demand for our services and products.

  • Risks Related to Our Business

    The success of our business is dependent on our ability to maintain and grow our network of OPTAVIA coaches

    Our financial performance depends on our network of active earning OPTAVIA coaches, which dropped to 27,100 as of December 31, 2024.

  • Risks Related to Our Business

    Our collaboration with LifeMD may not achieve the anticipated benefits

    Our strategic collaboration with telehealth company LifeMD to expand into the medically supported weight loss market may not achieve anticipated benefits.

  • Risks Related to Our Business

    The Collaboration may pose a number of risks, including: LifeMD has discretion in determining the efforts and resources that they will apply; LifeMD may not perform their obligations as expected; and LifeMD may fail to comply with applicable regulatory requirements

    Malpractice lawsuits against LifeMD healthcare professionals could be asserted against us or our independent OPTAVIA coaches.

  • Risks Related to Our Business

    Our direct selling model may be challenged, which could harm our business

    Government regulators may challenge our direct selling model under inherently fact-based legal requirements.

  • Risks Related to Our Business

    We may be subject to claims that our OPTAVIA coaches are unqualified to provide proper weight loss advice

    OPTAVIA coaches are independent contractors, and we cannot ensure they will comply with our policies when providing weight loss advice.

  • Risks Related to Our Industry

    Actions of activist stockholders could cause us to incur substantial costs, divert management's attention and resources, and have an adverse effect on our business

    Past targeting by activist stockholders could recur, causing substantial costs and diverting management attention.

  • Risks Related to Our Industry

    There can be no assurance that we will declare cash dividends in the future or in any particular amounts

    We updated our capital allocation priorities and discontinued our quarterly cash dividend.

All 29 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business

  1. 01The weight management industry is highly competitive and the development and acceptance of weight-loss medicines and other products could result in decreased demand for our services and products
  2. 02Deterioration of economic conditions, an economic recession or slow growth, periods of inflation or economic uncertainty, could continue to adversely affect consumer spending as well as demand for our products
  3. 03The success of our business is dependent on our ability to maintain and grow our network of OPTAVIA coaches
  4. 04If we do not continue to develop innovative new products or if our products do not continue to appeal to the market, or if we are unable to successfully expand or respond to consumer trends, our business may suffer
  5. 05Our collaboration with LifeMD may not achieve the anticipated benefits
  6. 06The Collaboration may pose a number of risks, including: LifeMD has discretion in determining the efforts and resources that they will apply; LifeMD may not perform their obligations as expected; and LifeMD may fail to comply with applicable regulatory requirements
  7. 07We could incur reputational harm or negative publicity in relation to an adverse event involving a LifeMD healthcare provider
  8. 08We may not be able to successfully implement new strategic initiatives, which could adversely impact our business
  9. 09channels such as Facebook, Instagram, X, and video conferencing platforms. If their advertising and marketing campaigns do not generate a sufficient number of customers, our business, financial condition and results of operations will be adversely affected
  10. 10Our direct selling model may be challenged, which could harm our business
  11. 11The FTC has also increased its scrutiny of the use of testimonials, which we also utilize, as well as the role of endorsers. We cannot be sure that the FTC will not challenge our advertising or other operations in the future, which could have a material adverse effect on our business
  12. 12Our ability to source quality ingredients and other products is critical to our business, and any disruption to our supply or supply chain could materially adversely affect our business
  13. 13We may be subject to claims that our OPTAVIA coaches are unqualified to provide proper weight loss advice
  14. 14We may be subject to health or advertising related claims from our customers
  15. 15We are dependent on our key executives for future success. If we lose the services of any of our key executives and we are unable to timely retain a qualified replacement, our business could be harmed
  16. 16Any failure of our technology or systems to perform satisfactorily could result in an adverse impact on our business
  17. 17Our business is subject to online security risks, including security breaches and identity theft
  18. 18be harmed. The effects of these new and evolving laws, regulations, and other obligations potentially are far-reaching and may require us to further modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply

Risks Related to Intellectual Property

  1. 19Third parties may infringe on our brand, trademarks and other intellectual property rights, which may have an adverse impact on our business
  2. 20We may in the future be subject to intellectual property rights claims

Risks Related to Our Industry

  1. 21Changes in consumer preferences could negatively impact our operating results
  2. 22The weight loss industry is subject to adverse publicity, which could harm our business
  3. 23Our industry is subject to governmental regulation that could increase in severity and hurt results of operations
  4. 24The manufacture and sale of ingested products are subject to product liability claims and other risks
  5. 25Actions of activist stockholders could cause us to incur substantial costs, divert management's attention and resources, and have an adverse effect on our business
  6. 26There can be no assurance that we will declare cash dividends in the future or in any particular amounts
  7. 27Our stock price fluctuates from time to time and may fall below expectations of securities analysts and investors, and could subject us to litigation, which may result in you suffering a loss on your investment
  8. 28Provisions in our certificate of incorporation may deter or delay an acquisition of us or prevent a change in control, even if an acquisition or a change of control would be beneficial to our stockholders
  9. 29If we do not maintain effective internal control over financial reporting, we could fail to report our financial results accurately

Other Medifast 10-Ks

  • FY2025 10-K risk factors
    27 risks3 new5 dropped8 reworded

    Medifast launched a strategic transformation in October 2025 focusing on holistic metabolic health to reverse steep declines in active earning coaches.

    Filed Feb 17, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.